TAAT® hosts an exhibitor booth and two private events at


LAS VEGAS and VANCOUVER, British Columbia, Sept. 30, 2022 (GLOBE NEWSWIRE) — TAAT® GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT®”) is pleased to announce that it will be hosting an exhibitor booth at the 2022 show hosted by the National Association of Convenience Stores (“NACS”, an event known as the “NACS Show”), during which TAAT® will also host two of the private events for “top-up” meetings with convenience industry executives attending the NACS Show. The 2022 NACS Show will be held at the Las Vegas Convention Center from Saturday, October 1 through Tuesday, October 4, 2022, with approximately 1,200 exhibitors. Historically, the NACS Show has drawn over 23,000 people from over 70 countries to each event. The NACS Show has ensured that there is an outdoor “smoking area” at the Las Vegas Convention Center to allow adult smokers to sample combustible products such as TAAT® at the show.

An overview of the company’s presence at NACS 2022 is provided below:

TAAT® exhibition stand: Hall North Level 1, booth #1171

  • Sunday, October 2, 2022: 11:30 a.m. to 5:30 p.m. (Pacific)
  • Monday, October 3, 2022: 11:30 a.m. to 5:30 p.m. (Pacific)
  • Tuesday, October 4, 2022: 9 a.m. to 1:30 p.m. (Pacific)

October 2 Afterparty: Cocktails and appetizers at Skyfall Lounge (Delano Las Vegas, attached to Mandalay Bay Resort & Casino)

  • Sunday, October 2, 2022: 8:30 p.m. to 11:30 p.m. (Pacific)

Afterparty on October 3: Cocktails and cigars at Eight Cigars Lounge (Resort World Las Vegas)

  • Monday, October 3, 2022: From 9 p.m. (Pacific)

At NACS 2022, the TAAT® booth is located in the North Hall, adjacent to the booths of well-known global brands in the amenities category, including JUUL Labs and Red Bull North America. In addition to this NACS Show presence, TAAT® will host two private events at resorts on the Las Vegas Strip for convenience industry executives.

Readers using news aggregation services may not be able to view the above media. Please access SEDAR or Investor Relations section of the Company’s website for a version of this press release containing all published media.

TAAT® CEO Michael Saxon said, “I anticipate TAAT®’s value proposition to stand out at the 2022 NACS Show, as a lower priced nicotine-free and tobacco-free alternative to cigarettes that is already appealing to consumers. adults. smokers in our target markets across the United States. This year, we’re focusing on how retailers can enjoy dramatically better profit margins selling TAAT® versus tobacco products. I’m especially excited about this event as we have Brent Taylor and Brad Call from B&B Beyond (announced in our September 13, 2022 press release) working with us at the show, and I believe we can benefit greatly from Brad’s experience as past president of the NACS organization. We look forward to kicking off the show this weekend and interacting with top leaders in commodity management across the United States and around the world.

More information about the NACS Show can be found on the event website at the following link: https://www.nacsshow.com/

On behalf of the Company’s Board of Directors,


“Michael Saxon”

Michael Saxon, CEO and Director

For more information, please contact:

TAAT® Investor Relations
1-833-TAAT-USA (1-833-822-8872)
[email protected]


About TAAT® Global Alternatives Inc.

TAAT® develops, manufactures and distributes alternative products in categories such as tobacco, hemp, kratom and other emerging CPG segments. Its flagship product is a nicotine- and tobacco-free fuel with a patent-pending base material formulation, sold in several thousand stores across the United States. With over $80 million CAD in annual gross revenue, TAAT® facilities include an operations center in Nevada, as well as a distribution center and multiple convenience stores in Ohio.

For more information, please visit http://taatglobal.com.

Forward-looking statements

This press release contains “forward-looking information” within the meaning of applicable Canadian securities laws. Often, but not always, forward-looking information and information can be identified by the use of words such as “anticipates”, “expects” or “does not expect”, “is expected”, “estimates “, “intends to”, “anticipates” or “does not anticipate”, or “believes”, or variations of these words and expressions or declare that certain actions, events or results “may”, “might” , “would”, “could” or “will” take, occur or be achieved. The forward-looking information in this press release includes statements regarding the anticipated performance of TAAT® in the tobacco industry, in addition to following: The potential results of the company’s presence at the 2022 NACS Show in addition to the two events it will host as detailed in the press release The forward-looking information reflects management’s current expectations based on the information currently available and are subject to a number of risks and uncertainties that may cause actual results to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in the preparation of the forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur within the time periods disclosed or not. at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes in the growth and size of tobacco markets; (iii) changes in the regulatory landscape applicable to the Company’s activities; and (iv) other factors beyond the Company’s control. The Company operates in a rapidly changing environment. New risk factors emerge from time to time, and it is impossible for the management of the Company to predict all risk factors, nor can the Company assess the impact of all factors on the business of the Company. Company or the extent to which any factor, or combination of factors, could cause actual results to differ from those contained in the forward-looking information. The forward-looking information included in this press release is made as of the date of this press release, and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. , except as required by applicable law.

The statements in this press release have not been evaluated by Health Canada or the United States Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claim or warranty can be made as to the effects of the Company’s products on the health and well-being of any individual. The Company’s products are not intended to diagnose, treat, cure or prevent any disease.

This press release may contain brand names of third-party entities (or their respective offerings with brand names) generally in reference to (i) the Company’s relationships with the third-party entities mentioned in this press release and/or (ii ) customers/suppliers/service providers whose relationship with the Company is/are mentioned in this press release. All rights in and to these marks are reserved by their respective owners or licensees.

Statement Regarding Third-Party Investor Relations Firms

Information about the investor relations firms retained by TAAT® Global Alternatives Inc. can be found under the company profile on http://sedar.com.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/435f9827-5664-4af4-a0ee-dd7d1bc88496


Comments are closed.